Abstract
Introduction
The genetic mucopolysaccharidoses (MPS)' are a group of 10 lysosomal storage diseases resulting from defects of specific lysosomal enzymes affecting glucosaminoglycan (GAG) degradation (1) (2) (3) (4) . MPS VI is characterized by growth retardation, facial abnormalities including frontal bossing, depressed nasal bridge, corneal opacity, hepatosplenomegaly, normal intelligence, and dysostosis multiplex (1) (2) (3) (4) . The enzyme defect, deficient arylsulfatase B (ASB) activity, results in the accumulation ofdermatan sulfate in tissues and fluids ofaffected individuals (1) (2) (3) (4) . Recently, the gene encoding human ASB has been isolated and characterized and the first mutations causing MPS VI in unrelated patients have been reported (5, 6) . Previously, an animal model of MPS VI was reported in the Siamese cat (7) (8) (9) . The feline model has been intensively investigated (7) (8) (9) and used as a model to develop and evaluate strategies for the treatment of the human counterpart. In this report, the clinical, morphologic, and biochemical features ofa newly recognized murine model of MPS VI are described. The availability of a small animal model of this disease should facilitate further evaluation of various therapeutic endeavors.
Pathological examination. 14 affected animals (12 males, 2 females) and 10 phenotypically normal littermates (8 Enzyme assays. The liver from three affected and three control rats used was thawed, cut into small pieces, and washed with cold saline to remove the blood. The hepatic tissues were homogenized in 5 vol of 10 mM sodium phosphate buffer, pH 6.0, containing 0.2% Triton X-100. The homogenates were centrifuged at 17,000 g for 30 min at 4°C, and the supernatants were used for enzyme assays. Arylsulfatase A (ASA) and ASB activities were determined using 4-nitrocatecol sulfate ( 14) as substrate; a-and f-galactosidase ( 15) , a-and f-mannosidase ( 16) , Figure 1 . A 13-wk-old ASB-deficient male rat (bottom) has shortened nose and tail and is smaller than its normal littermate (top).
ing the appropriate 4-methylumbelliferyl-fl-D-glycoside as substrate. The electrophoretic separation of ASA and ASB on cellulose acetate was performed essentially according to the method of Osanai and colleagues ( 19) . 15 Ml of each hepatic supernatant was applied as a 4-mmwide line on cellogel strips (5 x 6 cm), and electrophoresis was carried out in 0.06M Vernal buffer, pH 8.60, at 1 mA/cm for 45 min. Approximately 2-3 min before completion of electrophoresis, a filter paper, which was preabsorbed 14 mM 4-nitrocatechol-sulfate in 1 M sodium acetate buffer, pH 5.5 or 6.5, was placed into a Titan GEL isoenzyme incubation chamber. At the end of the electrophoresis period the sample strip was removed and blotted lightly. Then the sample strip was layered carefully onto the substrate filter paper and the sandwiched plate was incubated at 370C for 1 h. After incubation, the cellogel was exposed to the ammonia for visualization ofthe isoenzyme bands. And then immediately the strip was scanned in a densitometer using a 515-nm filter.
Pedigree analysis. Because the affected animals have poor fertility, the sires and dams producing the affected, designated as carriers, were used for genetic analysis. Carriers in the line were outcrossed with the Wistar King S (WKS) line. The incidence of mutants was observed in the F 1, F2, and backcross generations. In the F2 and backcross generations, litters produced by carrier Fl males and females were used for statistical analysis.
Results
Clinical observations. Compared with their normal littermates, affected animals had smaller bodies, shorter limbs, shorter and thicker tails, and a characteristic facial dysmorphia, including broad face, depressed nasal bridge, and a markedly shortened noses (Fig. 1 ) . The affected rats appeared grossly normal at birth; however, after 3 wk ofage, the abnormal features became evident. Macroscopically, the corneal opacity was not apparent and no gross neurologic or behavioral features were observed during the life span of the affected animals.
Pathology. Gross examination revealed no obvious organomegary; however, all vertebrae and long bones were shortened and the ribs were short and broad.
Microscopically, all affected animals showed characteristic changes in the cartilage ofthe joints and trachea. The articular cartilage showed an irregular growth plate and proliferation of vacuolated chondrocytes varied in size (Fig. 2) . Ultrastructually, the chondrocytes of the trachea were filled with single membrane-lined vacuoles, which were empty or contained a few fibrils (Fig. 3) . The growth plates were widened and irregular. The flattened tracheas observed in some mutants caused by thickened cartilage. The joints ofthe long bones in the affected animals showed proliferation of vacuolated synovial cells. The osseous tissue did not show marked changes except widened spaces of the osseous cells.
The vacuoles in the cytoplasm were characteristically observed in the macrophage system ofall mutant rats. Histochemically, the vacuoles described above showed positive reaction to colloidal iron and alcian blue stains and negative to PAS stain.
Furthermore, the vacuoles were not digested by hyaluronidase. Electronmicroscopically, the Kupffer cells were swollen with membrane-bounded inclusions, which were either empty or contained granular materials (Fig. 4) , although the mutant did not show hepatomegaly and/or splenomegaly. The mutant also showed mild vacuolation of the cells in the connective tissue of all organs.
No histological abnormalities were detected in the nervous system including of the brain, spinal cord, and sciatic nerve of the affected animals on paraffin-embedded sections.
Although the corneas of the affected animals did not show any changes in hematoxylin and eosin stain, they were slightly positive when stained with colloidal iron.
In the affected animals, most of the peripheral polymorphonuclear leukocytes contained excessive coarse granules in their cytoplasm (Fig. 5) .
Urinary GAG analyses. The GAG spot test on urine from all affected animals was positive, having an intensity comparable to that of a standard solution containing 100 Ag/ml of mixed chondroitin sulfate. In contrast, the urines from all normal animals were negative for GAGs by the spot test.
Total amounts of uronic acid determined by the carbazole and orcinol method in the affected and normal rats were 733±262 and 152±17 ,g/d and 1392±436 and 218±49 gg/d, respectively.
The electrophoretic patterns revealed that the primary GAG excreted by the affected animals was only dermatan sulfate (Fig. 6) .
Enzyme assays. The activities of selected lysosomal hydrolases in the liver from affected animals are shown in Table I . The ASB activity of the affected rats was < 5% of the mean activity in phenotypically normal control rats. There were no significant differences in the activities of other lysosomal hydrolases between the affected and normal animals. Electrophoresis of hepatic ASA and ASB from normal and affected rats revealed very low ASB activity in the affected animals (Fig. 7) . Pedigree analysis. To determine the mode of inheritance, parents of affected rats were reciprocally outcrossed with an unrelated line. In the Fl generation derived from parental males and outbreed females, there were no affected animals (Table II) . This finding fits the hypothesis described above, in which F1 animals include dominant homozygotes and hetero- Therefore, the incidences of affected animals in the offspring from matings of proven carrier females with proven carrier males were analyzed. The incidence of affected animals in the offsprings of parents of previous affected and in backcross generations were consistent with the expected value for autosomal single recessive transmission (Table II) .
Discussion
MPS VI (Maroteaux-Lamy syndrome) was first reported by Maroteaux and Lamy in the early 1960s (20, 21) . MPS VI resembles MPS I (Hurler syndrome) in physical features, but MPS VI patients have normal intelligence ( 1-4, 20, 21 ) . MPS VI results from ASB deficiency and is characterized by urinary excretion of excessive amounts of dermatan sulfate and controlled by an autosomal recessive single gene ( 1, 3, 4) .
Until now, however, there is no report of murine or rodent model for human MPS VI, although the feline model has been reported by Haskins and colleagues (7) (8) (9) (22) (23) (24) . A comparison of features in MPS VI between rats and human was shown in Table III . The clinical features of the mutant rats closely resembled those of MPS VI in the human and cat ( 1, 3, 4, 7-9, 22, 24) . Although the corneal clouding, one of features in MPS VI in the human and cat ( 1, 3, 4, 23) , was not grossly apparent in this mutant, slight storage of GAGs in the cornea could be confirmed by the histochemical investigation. Retardation tant shows deficiency of ASB activity. Lane I mutant; Lane 2 phenotypically normal rats. Because no abnormalities were detected in the nervous system ofthis mutant, there might be a possibility that this mutant rat maintains normal or near normal intelligence, as reported in man and cats (1) (2) (3) (4) 8) . However, further studies such as ultrastructural examination should be necessary to investigate nervous system in detail, since mentation in rodents is difficult to evaluate.
There have been few effective therapies for the patients with lysosomal storage diseases including MPS. Animal models of MPS were already reported in canine and feline MPS I (14, (26) (27) (28) , feline MPS VI (7) (8) (9) (22) (23) (24) , and canine and mouse MPS VII (18, (29) (30) (31) , and some experimental attempts for the therapy have been accomplished using the feline models of MPS I and MPS VI (32, 33) . However, no successful reports have been achieved. Recently, gene therapy has been attracted attention as a useful therapy of genetic diseases. Schuchman and colleagues (5) reported that the availability ofa full-length cDNA encoding human ASB permitted studies of this gene's structure, organization, and expression, and Jin and colleagues (6) described that the identification of the first molecular lesions in the ASB gene that caused MPS VI facilitated more accurate carrier testing and provided the basis for gentoype/ phenotype correlations for this disease (5, 6 ). This murine model is genetically well defined and homogeneous and provides an adequate number of animals to allow experiments. In addition, because of its small size, this mutant rat seems to be good for breeding, with such features as ease ofanimal care and low cost. Therefore, this mutant rat would be a very useful model to analyze the pathophysiology of MPS and also to investigate experimental therapies.
